These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30550479)

  • 21. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
    Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of magnetic resonance imaging in the evaluation of endometrial carcinoma.
    Aracki-Trenkic A; Stojanov D; Petric A; Benedeto-Stojanov D; Trenkic M; Ignjatovic J
    J BUON; 2016; 21(3):542-8. PubMed ID: 27569070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practice guidelines: uterine corpus--endometrial cancer. Society of Gynecologic Oncologists Medical Practice Committee.
    Oncology (Williston Park); 1998 Jan; 12(1):122-6. PubMed ID: 9474591
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical recommendations for diagnosing, treatment and monitoring of patients with endometrial cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].
    Karnjus-Begonja R; Vrdoljak E; Corusić A; Haller H; Jelavic TB; Matković V; Strinić T; Barisić D; Tomic S; Kukura V; Ban M; Padovan RS; Skalec SL; Belaj N; Puljiz M; Ferari AM; Hajredini A; Babic D; Mahovlić V; Pajtler M; ; ;
    Lijec Vjesn; 2013; 135(9-10):230-4. PubMed ID: 24364198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
    Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A report of the E.S.G.O. session during the Fifth European Meeting of the French Society of Gynecology "Recent data about endometrial carcinoma".
    Gorins A
    Eur J Gynaecol Oncol; 2001; 22(1):5. PubMed ID: 11321494
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of magnetic resonance imaging in preoperative staging of endometrial carcinoma according to International Federation of Gynecology and Obstetrics (2009) staging criteria].
    Du L; Lei Y; Li D; Qiu X; Liang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1048-51. PubMed ID: 22820597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous gynecologic cancer and the use of imaging for diagnosis.
    Boaventura CS; Galvão JL; Soares GM; Bitencourt AG; Chojniak R; Bringel SL; Brot LD
    Rev Assoc Med Bras (1992); 2016 Apr; 62(2):116-9. PubMed ID: 27167539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma.
    Gal D; Recio FO; Zamurovic D
    Cancer; 1992 Jan; 69(1):200-2. PubMed ID: 1727664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).
    Singh N; Hirschowitz L; Zaino R; Alvarado-Cabrero I; Duggan MA; Ali-Fehmi R; Euscher E; Hecht JL; Horn LC; Ioffe O; Matias-Guiu X; McCluggage WG; Mikami Y; Ordi J; Parkash V; Quddus MR; Quick CM; Staebler A; Zaloudek C; Nucci M; Malpica A; Oliva E
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S93-S113. PubMed ID: 30550486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of myometrial invasion in endometrial carcinoma].
    Peng P; Shen K; Lang J; Huang H; Wu M; Cui Q; Jiang Y; Tan L
    Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):679-82. PubMed ID: 12487925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features.
    Fadare O; Parkash V; Dupont WD; Acs G; Atkins KA; Irving JA; Pirog EC; Quade BJ; Quddus MR; Rabban JT; Vang R; Hecht JL
    Am J Surg Pathol; 2012 Aug; 36(8):1107-18. PubMed ID: 22790851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988.
    Mikuta JJ
    Cancer; 1993 Feb; 71(4 Suppl):1460-3. PubMed ID: 8431880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility of measurement of myometrial invasion in endometrial carcinoma.
    van der Putten LJ; van de Vijver K; Bartosch C; Davidson B; Gatius S; Matias-Guiu X; McCluggage WG; Toledo G; van der Wurff AA; Pijnenborg JM; Massuger LF; Bulten J
    Virchows Arch; 2017 Jan; 470(1):63-68. PubMed ID: 27787595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of the 2009 FIGO staging for endometrial cancer: an illustration of the E3N cohort.
    Koskas M; Chabbert-Buffet N; Bendifallah S; Luton D; Clavel-Chapelon F; Rouzier R
    Int J Gynecol Cancer; 2012 Mar; 22(3):447-51. PubMed ID: 22367322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.
    Scholten AN; Smit VT; Beerman H; van Putten WL; Creutzberg CL
    Cancer; 2004 Feb; 100(4):764-72. PubMed ID: 14770433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
    Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
    Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
    Hussein YR; Broaddus R; Weigelt B; Levine DA; Soslow RA
    Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preoperative detection of lymph nodes by means of computer tomography in patients with endometrial carcinoma].
    Pilka R; Kudela M; Dzvincuk P; Lubuský D
    Ceska Gynekol; 2004 May; 69(3):237-9. PubMed ID: 15310001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative MR imaging for ESMO-ESGO-ESTRO classification of endometrial cancer.
    Lavaud P; Fedida B; Canlorbe G; Bendifallah S; Darai E; Thomassin-Naggara I
    Diagn Interv Imaging; 2018 Jun; 99(6):387-396. PubMed ID: 29472031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.